MedTrace Logo

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2026-02-10

No results posted yet for this study

Summary

The aim of this study is to describe the outcomes in American Indian patients receiving immunotherapy in a multi-institution retrospective study at several other high-volume centers that care for this patient population and to identify any healthcare disparities that can lead to future interventional studies.

Conditions

Interventions

BIOLOGICAL

Immunotherapy

immunotherapy

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Abdul Naqash, MD · University of Oklahoma

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05863052 on ClinicalTrials.gov